跳至主要内容
临床试验/NCT07205471
NCT07205471招募中不适用

The Clinical Efficacy of Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients

Northern Jiangsu People's Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年9月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Change in Humoral Immune Markers from Baseline to 6 Months Postoperation

研究概览

简要总结

In this study,the researchers compared the changes in immune function-related indicators in patients with liver cirrhosis following laparoscopic partial splenectomy,to determine whether this surgical intervention can enhance postoperative immune function and thereby improve patient outcomes.

详细描述

Patients meeting the study's inclusion criteria were enrolled, and their baseline demographic data were collected. Eligible patients were randomly assigned in a 1:1 ratio to two groups: the laparoscopic splenectomy group and the laparoscopic partial splenectomy group, using a computer-generated randomization sequence. Following comprehensive preoperative preparation, all surgeries were performed by the same surgical team. The laparoscopic partial splenectomy technique involved preserving the short gastric vessels and the splenic suspensory ligament, with resection conducted along the demarcation line.

Postoperatively, all patients received standardized care from the same nursing team, followed by a uniform treatment protocol that included pharmacotherapy, additional therapeutic interventions, and follow-up assessments. Throughout the treatment period, monitoring was performed preoperatively and at 7 days, 1, 3, 6, and 12 months postoperatively. The parameters monitored included routine blood tests, liver function, coagulation profile, immune function, and hemodynamics of the portal vein, proper hepatic artery, and splenic vein.Additionally, indocyanine green (ICG) clearance tests were performed at 3, 6, and 12 months to assess liver function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
  • Splenomegaly with secondary hypersplenism
  • gastroesophageal variceal bleeding
  • Informed consent to participate in the study

排除标准

  • Hepatocellular carcinoma or any other malignancy,
  • Child-Pugh grade C
  • Recent peptic ulcer disease
  • History of Hemorrhagic stroke
  • Pregnancy.
  • Uncontrolled Hypertension
  • Human immunodeficiency virus (HIV) infection

结局指标

主要结局

Change in Humoral Immune Markers from Baseline to 6 Months Postoperation

时间窗: Baseline (preoperative) and 6 months postoperation

Serum levels of immunoglobulins (IgG, IgA, IgM), complement proteins (C3, C4), and B-cell markers (CD19, CD20) will be measured. The primary outcome is the change in these markers from preoperative baseline to 6 months after surgery.

Platelet Count at 6 Months Postoperation

时间窗: 6 months postoperation

Platelet count (×10⁹/L) will be measured and compared between the two surgical groups.

Hemoglobin Level at 6 Months Postoperation

时间窗: 6 months postoperation

Hemoglobin concentration (g/L) will be compared between groups.

Blood Flow Velocity of the Portal Vein at 6 Months Postoperation

时间窗: 6 months postoperation

Blood flow velocity (cm/s) in the portal vein, measured by Doppler ultrasound, will be compared between groups.

White Blood Cell Count at 6 Months Postoperation

时间窗: 6 months postoperation

White blood cell count (×10⁹/L) will be compared between groups.

Vascular Diameter of the Portal Vein at 6 Months Postoperation

时间窗: 6 months postoperation

Vascular diameter (mm) of the portal vein, measured by Doppler ultrasound, will be compared between groups.

Blood Flow Velocity of the Splenic Vein at 6 Months Postoperation

时间窗: 6 months postoperation

Blood flow velocity (cm/s) in the splenic vein, measured by Doppler ultrasound, will be compared between groups.

Indocyanine Green Retention Rate at 15 Minutes (ICG R15) at 6 Months Postoperation

时间窗: 6 months postoperation

Indocyanine green retention rate at 15 minutes (%), a measure of liver function, will be compared between groups.

Vascular Diameter of the Splenic Vein at 6 Months Postoperation

时间窗: 6 months postoperation

Vascular diameter (mm) of the splenic vein, measured by Doppler ultrasound, will be compared between groups.

Incidence of Portal Venous System Thrombosis within 6 Months Postoperation

时间窗: 6 months postoperation

The number of participants with newly developed thrombosis in the portal venous system, confirmed by imaging, will be recorded and compared.

次要结局

  • Comparison of Humoral Immune Marker Levels at 7 Days Postoperation(7 days postoperation)
  • Comparison of Humoral Immune Marker Levels at 3 months Postoperation(3 months postoperation)
  • Platelet Count at 3 Months Postoperation(3 months postoperation)
  • Platelet Count at 12 Months Postoperation(12 months postoperation)
  • White Blood Cell Count at 3 Months Postoperation(3 months postoperation)
  • Platelet Count at 1 Month Postoperation(1 month postoperation)
  • Comparison of Humoral Immune Marker Levels at 1 Month Postoperation(1 month postoperation)
  • Comparison of Humoral Immune Marker Levels at 12 Months Postoperation(12 Months postoperation)
  • Vascular Diameter of the Portal Vein at 12 Months Postoperation(12 months postoperation)
  • White Blood Cell Count at 1 Month Postoperation(1 month postoperation)
  • White Blood Cell Count at 12 Months Postoperation(12 months postoperation)
  • Hemoglobin Level at 1 Month Postoperation(1 month postoperation)
  • Hemoglobin Level at 3 Months Postoperation(3 months postoperation)
  • Hemoglobin Level at 12 Months Postoperation(12 months postoperation)
  • Blood Flow Velocity of the Portal Vein at 3 Months Postoperation(3 months postoperation)
  • Blood Flow Velocity of the Portal Vein at 12 Months Postoperation(12 months postoperation)
  • Vascular Diameter of the Portal Vein at 3 Months Postoperation(3 months postoperation)
  • Blood Flow Velocity of the Splenic Vein at 3 Months Postoperation(3 months postoperation)
  • Blood Flow Velocity of the Splenic Vein at 12 Months Postoperation(12 months postoperation)
  • Vascular Diameter of the Splenic Vein at 3 Months Postoperation(3 months postoperation)
  • Vascular Diameter of the Splenic Vein at 12 Months Postoperation(12 months postoperation)
  • Indocyanine Green Retention Rate at 15 Minutes (ICG R15) at 3 Months Postoperation(3 months postoperation)
  • Indocyanine Green Retention Rate at 15 Minutes (ICG R15) at 9 Months Postoperation(9 months postoperation)
  • Indocyanine Green Retention Rate at 15 Minutes (ICG R15) at 12 Months Postoperation(12 months postoperation)
  • Incidence of Portal Venous System Thrombosis within 12 Months Postoperation(12 months postoperation)
  • Incidence of Postoperative Complications within 30 Days(30 days postoperation)

研究者

发起方
Northern Jiangsu People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Guo-Qing Jiang

Clinical Professor

Northern Jiangsu People's Hospital

研究点 (1)

Loading locations...

相似试验